Product NDC: | 0115-8322 |
Proprietary Name: | ALPRAZOLAM |
Non Proprietary Name: | ALPRAZOLAM |
Active Ingredient(s): | 1 mg/1 & nbsp; ALPRAZOLAM |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0115-8322 |
Labeler Name: | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077968 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070524 |
Package NDC: | 0115-8322-02 |
Package Description: | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0115-8322-02) |
NDC Code | 0115-8322-02 |
Proprietary Name | ALPRAZOLAM |
Package Description | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0115-8322-02) |
Product NDC | 0115-8322 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ALPRAZOLAM |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20070524 |
Marketing Category Name | ANDA |
Labeler Name | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
Substance Name | ALPRAZOLAM |
Strength Number | 1 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |